Dermira completes phase II-b trials of its DRM04 product

admin
Site Admin
Posts: 370
Joined: Wed Dec 31, 1969 5:00 pm

Dermira completes phase II-b trials of its DRM04 product

Postby admin » Fri Nov 14, 2014 5:08 pm

http://money.cnn.com/news/newsfeeds/art ... 107901.htm

"DRM04 (topical anticholinergic) for hyperhidrosis. In August 2014, Dermira successfully completed a 198-patient, randomized, double-blind, vehicle-controlled Phase 2b dose-ranging study in primary axillary hyperhidrosis of a topical formulation of an anticholinergic agent that has been approved for systemic administration in other indications (referred to as the topical formulation of the reference agent). In the study, significant reductions in sweat production and improvements in other efficacy endpoints were observed in patients treated with select doses of the reference agent compared to vehicle. Also during the third quarter, Dermira completed enrollment in its ongoing, second Phase 2b study assessing the efficacy, safety and pharmacokinetics of DRM04, the topical formulation of the reference agent and vehicle. Data from this study, which enrolled approximately 100 patients with primary axillary hyperhidrosis, are expected during the first half of 2015. If successful, Dermira plans to initiate a Phase 3 program for DRM04 during the second half of 2015."

More about the DRM04 molecule:

http://dermira.com/pipeline/drm04/

admin
Site Admin
Posts: 370
Joined: Wed Dec 31, 1969 5:00 pm

Re: Delmira completes phase II-b trials of its DRM04 product

Postby admin » Sun Aug 09, 2015 3:06 pm



Return to “General Forum About Hyperhidrosis”

Who is online

Users browsing this forum: No registered users and 1 guest